EC Healthcare provided earnings guidance for the six months ended 30 September 2022. For the period, it is expected that the financial results of the Group may record a decrease of not more than 50% in profit after tax for the Reporting Period as compared with the Net Profit of approximately HKD 196.1 million for the corresponding period ended 30 September 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 HKD | -6.91% | -7.89% | +0.57% |
May. 13 | Hong Kong Bourse Allows EC Healthcare to Delay Circular Dispatch for Proposed Acquisition | MT |
May. 06 | EC Healthcare Sales Volume Unchanged for Q2 of Fiscal 2024 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.30% | 286M | |
-23.55% | 505M | |
+32.85% | 458M | |
-21.21% | 427M | |
-5.60% | 259M | |
-22.40% | 98.1M | |
-1.64% | 87.25M | |
-3.12% | 81.16M | |
-20.69% | 58.99M | |
-3.85% | 59.43M |
- Stock Market
- Equities
- 2138 Stock
- News EC Healthcare
- EC Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2022